Roberts Glore & CO Inc Bio Techne Corp Transaction History

Roberts Glore & CO Inc

$330 Million
Q1 2024

A detailed history of Roberts Glore & CO Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Roberts Glore & CO Inc holds 26,080 shares of TECH stock, worth $2.1 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

26,080

Previous 26,108 0.11%

Holding current value

$2.1 Million

Previous $2.01 Million 8.89%

% of portfolio

0.56%

Previous 0.63%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$65.98 - $77.09 $1,847 - $2,158	-28 Reduced 0.11%	26,080 $1.84 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $1,215 - $1,609	-18 Reduced 0.07%	26,108 $1.78 Million
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $28,618 - $33,360	-388 Reduced 1.46%	26,126 $2.13 Million
Q1 2023 May 08, 2023	SELL	$71.62 - $86.62 $7,018 - $8,488	-98 Reduced 0.37%	26,514 $1.97 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $1.58 Million - $6.89 Million	19,564 Added 277.58%	26,612 $2.21 Million

Q3 2022 Nov 07, 2022	SELL	$282.54 - $391.85 $16,387 - $22,727	-58 Reduced 0.82%	7,048 $2 Million
Q2 2022 Aug 11, 2022	SELL	$322.67 - $449.65 $18,392 - $25,630	-57 Reduced 0.8%	7,106 $2.46 Million
Q1 2022 May 02, 2022	SELL	$353.85 - $487.79 $19,107 - $26,340	-54 Reduced 0.75%	7,163 $3.1 Million
Q4 2021 Feb 11, 2022	SELL	$456.15 - $525.06 $31,474 - $36,229	-69 Reduced 0.95%	7,217 $3.73 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $266,922 - $323,328	-600 Reduced 7.61%	7,286 $3.53 Million
Q2 2021 Aug 10, 2021	SELL	$387.35 - $450.26 $38,735 - $45,026	-100 Reduced 1.25%	7,886 $3.55 Million
Q1 2021 May 06, 2021	SELL	$314.62 - $411.0 $17,933 - $23,427	-57 Reduced 0.71%	7,986 $3.05 Million
Q4 2020 Feb 09, 2021	SELL	$246.9 - $321.87 $1,234 - $1,609	-5 Reduced 0.06%	8,043 $2.55 Million
Q3 2020 Nov 06, 2020	BUY	$232.22 - $282.96 $1.87 Million - $2.28 Million	8,048 New	8,048 $1.99 Million
Q4 2019 Feb 13, 2020	SELL	$189.68 - $222.09 $1.11 Million - $1.3 Million	-5,851 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$183.56 - $216.72 $10,279 - $12,136	-56 Reduced 0.95%	5,851 $1.15 Million
Q2 2019 Aug 09, 2019	SELL	$188.72 - $215.43 $20,759 - $23,697	-110 Reduced 1.83%	5,907 $1.23 Million
Q1 2019 May 14, 2019	SELL	$136.09 - $200.44 $6,804 - $10,022	-50 Reduced 0.82%	6,017 $1.2 Million
Q4 2018 Feb 08, 2019	SELL	$132.75 - $203.8 $16,328 - $25,067	-123 Reduced 1.99%	6,067 $878,000
Q3 2018 Nov 09, 2018	SELL	$147.44 - $204.11 $194,620 - $269,425	-1,320 Reduced 17.58%	6,190 $1.26 Million
Q2 2018 Aug 10, 2018	SELL	$144.9 - $165.58 $26,951 - $30,797	-186 Reduced 2.42%	7,510 $1.11 Million
Q1 2018 May 08, 2018	SELL	$131.46 - $151.04 $46,011 - $52,864	-350 Reduced 4.35%	7,696 $1.16 Million
Q4 2017 Feb 09, 2018	SELL	$121.17 - $134.75 $4,362 - $4,851	-36 Reduced 0.45%	8,046 $1.04 Million
Q3 2017 Nov 08, 2017	SELL	$113.59 - $123.78 $28,397 - $30,945	-250 Reduced 3.0%	8,082 $977,000
Q2 2017 Aug 15, 2017	BUY	N/A	8,332	8,332 $979,000

Others Institutions Holding TECH

# of Institutions

590

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.16B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Account

Roberts Glore & CO Inc Bio Techne Corp Transaction History